Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_assertion type Assertion NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_head.
- NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_assertion wasGeneratedBy ECO_0000203 NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_provenance.
- NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_assertion wasDerivedFrom befree-2016 NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_provenance.
- NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_assertion SIO_000772 19277418 NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_provenance.
- NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_assertion evidence source_evidence_literature NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_provenance.
- NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_assertion description "[JAK2 V617F was detected in 89 (61%) patients with ET, 103 (86%) with PV, four (33%) with myelofibrosis, and four (80%) with MPNu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP725324.RA4XqMCpoSJ9mEcYUjwSDGkM4cV5ICHQqIL1-fgkbvJJQ130_provenance.